NRP1 and cancer: T cell and NK92 cell-derived extracellular vesicles or artificial cell-derived vesicles (ACDVs) exhibit anti-cancer effects through inherited cytotoxic proteins like perforin and granzyme or transmembrane receptors like FasL and TRAIL.